Biopharmaceutical New Technologies (BioNTech) Corporation, 55131 Mainz, Germany.
Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA .
Cells. 2019 Oct 5;8(10):1205. doi: 10.3390/cells8101205.
Subverting the conventional concept of "the" ribosome, a wealth of information gleaned from recent studies is revealing a much more diverse and dynamic ribosomal reality than has traditionally been thought possible. A diverse array of researchers is collectively illuminating a universe of heterogeneous and adaptable ribosomes harboring differences in composition and regulatory capacity: These differences enable specialization. The expanding universe of ribosomes not only comprises an incredible richness in ribosomal specialization between species, but also within the same tissues and even cells. In this review, we discuss ribosomal heterogeneity and speculate how the emerging understanding of the ribosomal repertoire is impacting the biological sciences today. Targeting pathogen-specific and pathological "diseased" ribosomes promises to provide new treatment options for patients, and potential applications for "designer ribosomes" are within reach. Our deepening understanding of and ability to manipulate the ribosome are establishing both the technological and theoretical foundations for major advances for the 21 century and beyond.
颠覆“传统”核糖体的概念,大量来自于近期研究的信息揭示出核糖体远比传统观点所认为的更加多样和具有动态性。各种不同的研究人员正在共同阐明一个充满异质和适应性核糖体的宇宙,这些核糖体在组成和调控能力上存在差异:这些差异使核糖体能够实现专业化。核糖体的扩展宇宙不仅在物种之间的核糖体专业化方面包含了令人难以置信的丰富性,而且在同一组织甚至细胞内也是如此。在这篇综述中,我们讨论了核糖体的异质性,并推测了对核糖体库的新兴理解如何影响当今的生物科学。针对病原体特异性和病理性“疾病”核糖体的靶向治疗有望为患者提供新的治疗选择,而“设计核糖体”的潜在应用也触手可及。我们对核糖体的深入理解和操纵能力正在为 21 世纪及以后的重大进展奠定技术和理论基础。